Ivermectin Shows ‘Antiviral Effect’ Against Omicron, Japanese Company Says

The great reversal of the COVID-19 narrative continues with reports of an ivermectin study from Japan.

Japanese trading and pharmaceutical company Kowa Co Ltd stated on Monday that ivermectin showed an “antiviral effect” against omicron and other variants.

The firm has has been working with Kitasato University, a medical university in Tokyo, and did not provide further details.

NEW: Kowa in Japan found that ivermectin has an antiviral effect on Omicron – Reuters reporthttps://t.co/wFUgU6aFlg

— Insider Paper (@TheInsiderPaper) January 31, 2022

"The trial found ivermectin has “an antiviral effect” against the variant, Kowa said without providing further details. The firm has been working with Kitasato University, a medical university in Tokyo."https://t.co/Ex6oQtINkq

— Tim Röhn (@Tim_Roehn) January 31, 2022

HUH that's something independent journalists and researcher's have been telling you for many months NOW!!!https://t.co/bgSsF4ZTLy

— Luke Rudkowski (@Lukewearechange) January 31, 2022

Japan's Kowa says ivermectin showed 'antiviral effect' against Omicron https://t.co/dmVZlDDJSb

— FLCCC—Front Line COVID-19 Critical Care Alliance (@Covid19Critical) January 31, 2022

Reuters backtracked from their original article that stated ivermectin showed effectiveness against omicron in Phase III clinical trials:

(Corrects headline and first paragraph to remove reference to the drug being effective in treating against Omicron in Phase III clinical trials)

cont.

Clinical trials evaluating the drug, which is used to treat parasites in animals and humans, are ongoing but promotion of the drug as a COVID-19 treatment has generated controversy here.

The drug is not approved for treatment of COVID-19 in Japan and the U.S. Federal Drug Administration has repeatedly warned against its use.

As WLT reported, Japan witnessed a dramatic decline in COVID-19 cases upon the usage of ivermectin in August 2021.

While we’ve reported the truth about ivermectin for months, the mainstream media’s false narrative is slipping from their grasp.

Yahoo News attempted to downplay the positive news:

The use of ivermectin to treat COVID-19 is currently being investigated in a UK trial run by the University of Oxford. The researchers said on Monday that it was still under way and they did not want to comment further until they have results to report.

Many potential COVID-19 treatments that showed promise in test tubes, including the antimalarial hydroxychloroquine promoted by former U.S. President Donald Trump, ultimately failed to show benefit for COVID-19 patients once studied in clinical trials.

Monday’s news follows reports of a Mexico study showing a treatment kit containing ivermectin reduced COVID-19 hospitalizations and deaths.